Vanadate (10 mM), a potent inhibitor of tyrosine phosphatase, added simultaneously potentiated BuONainduced (1 mM) apoptosis. The steady-state level of nucleophosmin/B23 mRNA and the total cellular nucleophosmin/B23 protein decreased during the BuONa/vanadate-induced apoptosis. Stabilization and promotor transcriptional activity assays indicate that the decrease in nucleophosmin/B23 mRNA in BuONa/ vanadate-treated HL-60 cells was transcriptionally regulated. A decline in telomerase activity was observed in HL-60 cells treated with BuONa/vanadate for 24 ± 96 h. There was virtually no decline of nucleophosmin/ B23 mRNA nor the telomerase activities during the growth arrest by serum-starvation. The decrease in nucleophosmin/B23 mRNA expression and telomerase activity in HL-60 cells subsequent to BuONa/vanadate treatment can thus be attributed to cellular apoptosis rather than the growth arrest induced by BuONa/ vanadate. Nucleophosmin/B23 antisense oligomer treatment signi®cantly potentiated BuONa-induced apoptosis and inhibition of telomerase activity. Results of this study suggest that nucleophosmin/B23 is one of the key elements in the down-regulation of nucleolar function for cellular apoptosis and mortalization.
Introduction
Apoptosis (Kerr et al., 1972) , the physiological mode of cell death, is representative of an endogenous cell suicide mechanism which can be selectively triggered by cells in response to as yet largely unknown stimuli. During apoptosis, a series of well de®ned degenerative changes occur within the cell (Kerr et al., 1972; Duvall and Wyllie, 1986) which ultimately results in the degradation of the nuclear DNA into oligonucleosome chains (Wyllie, 1980) and the fragmentation of the cell into neat`bite-size' pieces for ecient disposal by neighboring cells or marauding macrophages (Savill et al., 1989) . According to Wyllie et al. (1980) , at a morphological level, necrosis is associated with cell swelling, the rupture of membranes, and the dissolution of an organized structure while apoptosis is characterized by cell shrinkage and chromatin condensation.
Apoptosis has been described as a programmed, as opposed to accidental death of cells (Kerr et al., 1972) .
The identi®cation of genes and their products that are involved in response to growth stimuli is essential for understanding of the normal cell growth and death. During the past decade, numerous regulatory factors which control the balance between a cycling and quiescent state have been identi®ed. These factors include protooncogens and negative and positive regulatory growth factors. Other proliferation-associated molecules are being studied to determine their potential role in cell growth regulation (Fonagy et al., 1992; Chou and Yung, 1995) . Nucleophosmin/B23, also called protein B23, NO38, or numatrin (SchmidtZachmann et al., 1987; Yung et al., 1985) , is a major nucleolar phosphoprotein that displays a number of activities. These include a potential role as a positive regulator of cell proliferation. Nucleophosmin/B23 is signi®cantly more abundant in tumor and proliferating cells than normal resting cells (Feuerstein et al., 1988; Chan, 1989) . Steady-state levels of nucleophosmin/B23 have also been determined in normal and abnormal growth . Nucleophosmin/B23 mRNA is 50-and ®vefold higher in Noviko hepatoma and hypertrophic rat liver, respectively, when compared to normal rat liver . Nucleophosmin/B23 is localized in granular regions of the nucleolus (Spector et al., 1984; Peculis and Gall, 1992) , associated with preribosomal particles (Prestayko et al., 1974; Yung et al., 1985) and forms hexamers (Yung and Chan, 1987) which may be essential for the assembly of ribosomes. Our previous studies have shown that nucleophosmin/B23 translocates from nucleoli to nucleoplasm during the stationary phase of growth (Yung et al., 1990a) or during treatment with certain anti-tumor drugs, particularly the DNA intercalators (Yung et al., 1985 (Yung et al., , 1986 (Yung et al., , 1990b Wu et al., 1995) . Study by Valdez et al. (1994) demonstrates that nucleophosmin/B23 binds to amino acid sequence 24 ± 56 of protein p120, a cell cycle related protein. In light of many potential roles of nucleophosmin/B23, it is conceivable that nucleophosmin/B23 plays a role in the regulation of cell proliferation.
Normal diploid somatic cells lose approximately 50 ± 200 bp of telomeric DNA/mean population doubling due to the inability of DNA polymerase to completely replicate the ends of linear chromosomes (Harley et al., 1990) . In contrast, germ lines and most immortal cell lines maintain their telomeres at a constant length irrespective of the number of divisions they undergo due to the enzyme activity of telomerase activity, a ribonucleoprotein that is able to synthesize and add telomeric repeats onto chromosomal termini. Because telomerase activity is absent in most normal human somatic cells and tissues that have limited replicative spans (Kim et al., 1994) but is activated during cellular immortalization (Counter et al., 1992) , the telomere hypothesis of cell aging and immortalization has been proposed, in which the attrition of telomeric sequences ulitimately interferes with the expression of genes required for continued cell growth (Allsopp et al., 1992; Wright and Shay, 1992) . Strong correlative support for this hypothesis was provided by the observation of telomerase activity in 98% of established immortal cell lines and 90% of tumors tested and the absence of telomerase activity in over 50 normal human somatic tissues (Kim et al., 1994) .
Our recent ®ndings demonstrate that nucleophosmin/B23 is transcriptionally down-regulated during retinoic acid (RA) induced cellular dierentiation of HL-60 promyelocytic leukemia cells (Hsu and Yung, 1998) . The potentiation of RA-induced dierentiation by nucleophosmin/B23 antisense oligomer further implicates that nucleophosmin/B23 plays an important role in the down regulation of nucleolar function for cellular dierentiation. Telomerase activity is also recently found to be inhibited during terminal dierentiation of immortal cell lines (Bestilny et al., 1996; Albanell et al., 1996) . Whether the decrease of nucleophosmin/B23 mRNA as a result of antisense treatment would render tumor cells more susceptible to chemotherapeutics or induction of apoptosis becomes an important question to be addressed.
Sodium butyrate (BuONa) is a potent cell growth inhibitor, dierentiation and apoptosis inducers (Kruh, 1982; Calabresse et al., 1993; Hague et al., 1993) . Our previous results (Chang and Yung, 1996) has shown that vanadate, an inhibitor of tyrosine phosphatase, added simultaneously could potentiate BuONa-induced cell growth inhibition and apoptosis. In order to gain insight into the biological role of nucleophosmin/B23 in regulation of cell growth and cell mortalization, attempts were made in the present study to determine the changes of nucleophosmin/B23 and telomerase activities during BuONa/vanadate-induced apoptosis. We hypothesize that down-regulation of nucleophosmin mRNA may be one of the important steps for blocking the`normal' cells from becoming`abnormal' or a step towards making immortal cancer cells mortal. Our study demonstrates that the use of nucleophosmin/ B23 antisense oligonucleotides to down-regulate nucleophosmin/B23 mRNA could result in mortalization of cells as evidenced by having cells being more susceptible to induction of apoptosis and loss of telomerase activity.
Results
Nucleophosmin/B23 mRNA during BuONa/vanadate induced apoptosis
The growth of HL-60 cells was inhibited by 1 mM BuONa (Figure 1a) . Vanadate added simultaneously with BuONa potentiated the growth inhibition. Culturing cells in the presence of 10 mM vanadate alone produced virtually no eect on HL-60 cell growth (Figure 1a) . After 72 h of incubation with 1 mM BuONa in the presence of 10 mM vanadate, cell viability decreased (*60%) and apoptotic cells became abundant (*40%) in respect to control cells and the cells treated with 1 mM BuONa alone (Figure 1b) . After 96 h of BuONa/vanadate co-treatment, most (*90%) of cells exhibited the morphological characteristic of apoptosis and there was further decrease in the viability (510%) of treated cells (Figure 1b) . A single mRNA band hybridizing with the nucleophosmin/B23 cDNA probe was observed in the Northern blot of rapidly proliferating promyelocytic leukemic HL-60 cells (control, Figure 2a ). The steady-state level of nucleophosmin/B23 mRNA, as determined by the levels of radioactivity of the hybridizing bands, decreased during the BuONa-induced apoptosis (Figure 2 ). The decrease of nucleophosmin/B23 mRNA to more extent was observed for cells treated with BuONa in the presence of vanadate (Figure 2) . After 48 h of BuONa/vanadate co-treatment, nucleophosmin/B23 expression decreased to about 40% and continued to decrease to less than 20% after 72 h.
Eect of BuONa/vanadate on nucleophosmin/B23 protein level
Total cellular protein samples (containing equal amounts of protein) from control untreated HL-60 cells and the HL-60 cells treated with 1 mM BuONa in the absence or presence of 10 mM vanadate for various times (24 ± 96 h) were separated by 10% SDS ± PAGE and subsequently analysed by Western blot immunoassay. The lower and upper panels of Figure 3a shows the Commassie blue-stained SDS ± PAGE and chromogenic diagrams of Western blot analysis, respectively. The immunobands of nucleophosmin/B23 were present in all the control untreated and BuONa/vanadatetreated cells. The results after densitometry analysis ( Figure 3b ) indicated that there was down-regulation of nucleophosmin/B23 in total cellular protein level of nucleophosmin/B23 during BuONa-induced apoptosis. A much decreased nucleophosmin/B23 total protein level was observed in cells treated with BuONa in the presence of vanadate (Figure 3b ).
Nucleophosmin/B23 mRNA expression is transcriptionally down-regulated during BuONa/ vanadate induced apoptosis
To compare the stability of nucleophosmin/B23 transcripts in control (uninduced) versus BuONa/ vanadate-treated (2 days) HL-60 cells, the half-lives of nucleophosmin/B23 mRNA transcripts were analysed by incubating the cells with actinomycin D (10 mg/ml) for up to 8 h ( Figure 4a ). HL-60 cells had been treated with 1 mM BuONa in the presence of 10 mM vanadate for 2 days before the addition of actinomycin D. The densitometry analysis showed that there were virtually no dierences in the half-lives in the treated cells as compared to control uninduced cells ( Figure 4b ). Thus, the marked decrease in nucleophosmin/B23 mRNA levels during BuONa/vanadateinduced apoptosis was not due to post-transcriptional regulation.
To determine whether nucleophosmin/B23 mRNA transcripts are decreased in HL-60 cells during BuONa/vanadate-induced apoptosis because of the alterations of transcriptional activity in nuclei, promotor activity assays were carried out. The nucleophosmin/B23 promotor transcriptional activity after incubation of HL-60 cells with 1 mM BuONa in the presence of 10 mM vanadate for 24 and 48 h is shown in Figure 5 . There were signi®cant decreases in the nucleophosmin/B23 promotor transcription after 48 h treatment of HL-60 cells with BuONa/vanadate ( Figure 5 ).
Eect of BuONa/vanadate on telomerase activity
Studies were also conducted to analyse the telomerase activity in HL-60 cells treated with BuONa in the absence or presence of vanadate. A decline of telomerase activity in BuONa-treated versus untreated was observed over time (Figure 6 Little changes in nucleophosmin/B23 mRNA expression and telomerase activity after growth arrest without apoptosis HL-60 cells do arrest growth when deprivated of serum from the growth medium. In serum growth-arrested cells, the abundance of nucleophosmin/B23 mRNA (previously shown, Hsu and Yung, 1998) and the telomerase activity did not change ( Figure 7 ). In contrast to the decrease of c-myc mRNA expression Figure 1 Eect of BuONa in the absence or presence of vanadate on cellular growth, viability and apoptosis. HL-60 cells were treated with 1 mM BuONa in the absence or presence of 10 mM vanadate for various times (24 ± 96 h). Cultures were then harvested and cell numbers were obtained by counting cell suspensions with hemocytometer (Cell growth, a). The levels of apoptotic and viable cells were determined as described under Materials and methods. (b) . The ®gure is a representative of the results obtained in at least three independent experiments. Points, means of triplicates in serum-starved HL-60 cells (Hsu and Yung, 1998) or in previous study in F9 cells (Dean et al., 1986) , the decline of the expression of nucleophosmin/B23 mRNA and the down-regulation of telomerase activity are rather related to induced-apoptosis than the growth arrest during the treatment with BuONa/vanadate.
Potentiation of BuONa-induced apoptosis and inhibition of telomerase activity by nucleophosmin/B23 antisense oligomer
The use of antisense oligonucleotides have been proposed as a method for elucidating the function of speci®c genes. There was signi®cant decrease in mRNA level of nucleophosmin/B23 in the cells treated with nucleophosmin/B23 antisense oligomer as compared to the control untreated cells (previously shown, Hsu and Yung, 1998) . Nucleophosmin/B23 antisense oligomer treatment potentiated BuONa-induced (1 mM, 24± 96 h) inhibition of cell growth ( Figure 8a ) and induction of apoptosis (Figure 8b,c) . About 20 ± 25% of control untransfected or the nucleophosmin/B23 reverse oligomer-transfected cells exhibited the morphological characteristic of apoptosis and there was decrease in the cell viability (down to about 75 ± 70%) after 72 ± 96 h of BuONa treatment (Figure 8b,c) . About 40 ± 58% of cells transfected with nucleophosmin/B23 antisense oligomer, on the other hand, became apoptotic and there was further decrease in cell viability (down to about 60 ± 40%) after incubation with 1 mM BuONa for 72 ± 96 h (Figure 8 ). Nucleophosmin/B23 reverse or antisense oligomer alone without addition of BuONa caused virtually no eect on inhibition of cell growth and induction of apoptosis of HL-60 cells. Furthermore, nucleophosmin/B23 antisense oligomer treatment could also potentiate BuONa-induced (1 mM, 72 ± 96 h) inhibition of telomerase activity (Figure 9 ). The telomerase activity decreased to about 40 ± 15% in untransfected or the nucleophosmin/B23 reverse oligomer-transfected cells after incubation with BuONa for 72 ± 96 h. There was further decrease of telomerase activity to 15-2% in anti-sense transfected cells after incubation with BuONa for 72 ± 96 h ( Figure 9 ).
Discussion
Tumors are usually recognized by the fact that the cells have shown abnormal immortal growth. Tumor cells dier from normal mortal cells in that they are no longer responsive to normal growth controlling P-labeled 18S cDNA probe that was used as a control for the amount of RNA loaded. (b) the nucleophosmin/B23 mRNA levels were quanti®ed by comparing band intensities that were determined by densitometry scanning. All values were normalized with the intensites of probed 18S ribosomal RNAs Figure 3 Eect of BuONa in the absence or presence of vanadate on total nucleophosmin/B23 protein level. HL-60 cells were treated with 1 mM BuONa in the absence or presence of 10 mM vanadate for various times (24 ± 96 h). Cells were then harvested, washed and the lysates were centrifuged at 12 000 g for 30 min at 48C. (a) 30 mg of total cellular proteins were separated by 10% SDS ± PAGE stained with Coomassie Blue (lower panels) or blotted onto PVDF papers (upper panels). The blotted papers were incubated with monoclonal antinucleophosmin/B23 antibody for 2 h at room temperature. Immunoreactivity was determined using the chromogenic development. (b) the nucleophosmin/B23 protein immuno-band intensities were determined by densitometry scanning. One hundred per cent represents the nucleophosmin/ B23 protein levels of untreated cells mechanisms. Current chemotherapeutic drugs act for the most part by killing cancer cells directly while normal cells are also seriously damaged. Researchers have begun trials of agents that act instead by changing the biological properties of cancer cells so that they lose one of the major characteristics, namely, the ability to divide continuously. The new work on tumor dierentiation and apoptosis aims to shift the balance back again, thereby removing the potential for uncontrolled growth from the tumor cells.
One important dierence between cancer and normal cells is hyperactivity and pleomorphism of the nucleoli (Busch, 1963) . The nucleolus in cancer cells undergoes extreme variations in size, shape, ®ne structure, and cytochemical composition (Bernhard and Granboulan, 1968) . Little information is currently available on the nucleolar proteins, their characterization and their role in growth and in cancer cells. Many of our studies and others have indicated that nucleophosmin/B23, one of the major nucleolar phosphoprotein, plays a role in increased nucleolar activity that is necessary for cell proliferation (Feuerstein and Mond, 1987; Feuerstein et al., 1988; Yung et al., 1990b) . Nucleophosmin/B23 is of potential interest because it is involved in at least three distinct forms of hematologic malignancy. The N-terminal region of nucleophosmin/B23 is fused to ALK tyrosine kinase in anaplastic lymphoma with t(2;5) (Morris, 1994) , retinoic acid receptor a in acute promyelocytic leukemia with t(5;17) (Redner et al., 1996) , and a novel gene called MLF1 in myelodyplastic syndrome with t(3;5) (Yoneda et al., 1996) . It is important for us to show recently that downregulation of nucleophosmin/B23 mRNA is associated with cellular dierentiation of HL-60 promyelocytic leukemia cells. Nucleophosmin/B23 may be one of the key elements in the down-regulation of nucleolar function for cellular dierentiation.
Activation or up-regulation of telomerase is a known feature of immortal cancer cells (Kim et al., 1994; Counter et al., 1992; Hiyama et al., 1995) , and there is a reverse relationship between the degree of dierentiation and the level of telomerase activity down-regulation (Albanell et al., 1996; Bestilny et al., 1996) . Down-regulation of telomerase activity (Bestilny et al., 1996) and nucleophosmin/B23 mRNA (Hsu and Yung, 1998) are observed in response to differentiation-inducing agent retinoic acid in HL-60 cells. The aim of our present study is therefore to elucidate the possible correlation between regulation of nucleophosmin/B23 and cell immortalization. In the analysis of the cellular apoptosis, telomerase activity and nucleophosmin/B23 in BuONa/vanadate-treated HL-60 cells, association between telomerase activity and the level of nucleophosmin/B23 mRNA is obtained. Down-regulation of nucleophosmin/B23 mRNA by the antisense treatment is able to make the cells more susceptible to BuONa/vanadate in the induction of apoptosis and inhibition of telomerase activities.
In support of the notion that down-regulation of nucleophosmin/B23 plays a role in cell proliferation, Figure 6 Eect of BuONa in the absence or presence of vanadate on telomerase activity. HL-60 cells were treated with 1 mM BuONa in the absence or presence of 10 mM vanmadate for various times (24 ± 96 h). (a) cells were then harvested, washed and the lysates were centrifuged at 12 000 g for 30 min at 48C. The telomerase activities were then determined by TRAP assay. (b) Signal intensity in each lane was measured by area integration of the ®rst six ladders from the bottom of the gel using Phosphoimager. Relative telomerase activities were quantitated by comparing the signal intensity in each lane, and using positive control (CTL (+), extract of untreated cells) as 100%. Negative control (CTL (7)), no extract added Figure 7 Growth arrest and telomerase activity. HL-60 cells were grown in serum-free medium for 24 ± 96 h. (a) cells were harvested, washed and the lysates were centrifuged at 12 000 g for 30 min at 48C. The telomerase activities were then determined by TRAP assay. (b) Signal intensity in each lane in (a) was measured by area integration of the ®rst six ladders from the bottom of the gel using Phosphoimager. Relative telomerase activities were quantitated by comparing the signal intensity in each lane, and using that of 0 h as 100%. Negative control (CTL (7)), no extract added previous ®ndings indicate that the steady-state level of nucleophosmin/B23 mRNA is signi®cantly higher in abnormal growth as compared to normal growth. In our recent analysis of the clinical gastric cancer tissues, the sizes of tumor extension and the stages of cancer are found to be somehow related to nucleophosmin/B23 mRNA levels. Cancers of later stages seemed to have higher nucleophosmin/B23 mRNA levels in relative to the matched adjacent normal' gastric mucosa (unpublished results). These results indicate that nucleophosmin/B23 is importantly associated with cancer. The other important ®ndings about nucleophosmin/B23 related to these studies were that of Patterson et al. (1995) who reported a decrease in nucleophosmin/B23 labeling in apoptotic cells and that of Feuerstein and Mond (1987) , who reported a 68% inhibition of synthesis of nucleophosmin/B23 as a result of anti-m-induced growth arrest. Our studies have importantly demonstrated that the tumor cells treated with nucleophosmin/B23 antisense oligomers containing markedly reduced levels of nucleophosmin/B23 mRNA are more`mortal' as evidenced by being more susceptible and prone to be induced to dierentiate (Hsu and Yung, 1998) , to die apoptotically and to the inhibition of telomerase activity (the present study). The potentiation ability of nucleophosmin/B23 antisense in induced cellular dierentiation, apoptosis and the inhibition of telomerase activity is particularly interesting and may lead to the use of antisense construct in cancer treatment. In any case, nucleophosmin/B23 gene is implicated to have a functional role in growth control, and its down-regulation could be closely associated with mortalization of tumor cells.
Important future studies will thus be to elucidate the mechanism of the potentiation of induction of cellular dierentiation, apoptosis and inhibition of telomerase activities under the antisense oligomer treatment and eventually to understand how nucleophosmin/B23 plays a role in the regulation of nucleolar function for cellular growth. Down-regulation of nucleophosmin/B23 in a cascade of mechanism of tumorigenesis may be an important step for blocking the`normal' cells from becoming`abnormal' or a step towards making immortal cancer cells mortal.
Materials and methods

Drugs and chemicals
Sodium butyrate (BuONa), vanadate, DL-dithiothreitol (DTT) and phenylmethylsulfonyl¯uoride (PMSF) were purchased from the Sigma Chemical Co. The dyes Wright and trypan blue were from Sigma, and the Giemsa stain was purchased from Aldrich Chemical Co. 
Cells
The HL-60 promyelocytic leukemic cells were grown in RPMI-1640 supplemented with 10% heat-inactivated fetal bovine serum, 2 mM glutamine, 50 units/ml penicillin and 50 mg/ml streptomycin in a 5% CO 2 humidi®ed incubator at 378C.
Cell growth determination
HL-60 cells (approximately 2610
5 /ml) were grown in 75-cm 2 plastic tissue culture¯asks in growth medium and maintained without refeeding throughout the experiment. Every 24 h for 4 days, cultures from each set were harvested and monitored for cell number by counting cell suspensions with hemocytometer. Cell viability was assessed by exclusion of 0.2% trypan blue.
Assessment of apoptotic cells
Morphological assessment of the apoptotic cells was performed using the Wright-Giemsa staining method. Cells (5610 4 ) were prepared on slides by Cytospin (Shandon Southern) and stained with Wright-Giemsa stain. The morphology of cells was examined under light microscope (61000). Apoptotic cells were identi®ed according to the following criteria: condensed and fragmented nuclei, blebbing of plasma membrane and decrease in cell size. Triplicate 200-cell counts were performed.
Electrophoresis
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE) was carried out according to the protocol of Laemmli (1970) .
Immunoblot analysis
Control and BuONa-treated HL-60 cells were harvested, washed twice in ice-cold PBS and lysed in RIPA buer (1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 20 mM Na 2 HPO 4 , 100 mM NaCl, 20 mM NaF, 0.2 mM PMSF, 1 mM DTT, 30 mg/ml DNase and 30 mg/ml RNase). The lysates were boiled in SDS sample buer (62.5 mM Tris, pH 6.8, 5% b-mercaptoethanol, 10% glycerol, 2.0% SDS, 0.001% bromophenol blue) and the cell extract was fractionated by 10% SDS polyacrylamide gel eletrophoresis. The separated proteins in SDS ± PAGE were electrotransferred to Hybond-PVDF membrane (Amersham). The PVDF membrane was then soaked in a blocking solution (5% (w/v) non-fat milk in TBST buer (20 mM Tris-HCl, pH 7.5, 0.5 M NaCl, 0.1% (v/v) Tween-20)) for 1 h at room temperature. The soaked PVDF membrane was then incubated with MAb against nucleophosmin/B23 (diluted 1 : 2000 in 3% (w/v) non-fat milk in TBST) for 1 h at room temperature, washed with TBST buer three times for 15 min each and incubated at room temperature for 1 h in horse-radish peroxidase conjugated goat anti-mouse IgG antibody (diluted 1 : 2000 in TBST buer). The membrane was washed three times with TBST for 15 min each. Immunoreactivity was determined using the chromogenic development.
Oligonucleotides
The phosphorothioate analogs of deoxyoligonucleotides corresponding to nucleotides 72*18 of the nucleophosmin/B23 cDNA (Li et al., 1989) were synthesized in the reverse (5'-GCT ACC TTC TAA GCT ACC TG-3') and the antisense (5'-GTC CAT CGA ATC TTC CAT CG-3') orientations (ASIA Company Ltd., Oregon-Wilsonville). These synthetic deoxyoligonucleotides comprised the 5'-region of the nucleophosmin/B23 cDNA including the translation initiation codon.
RNA analysis
Total RNA was prepared from HL-60 cells by ULTRA-SPEC TM RNA Isolation System (Biotecx). For Northern blot analysis, aliquots of 3 mg of RNA were separated by 1.2% formaldehyde agarose gel electrophoresis, transferred to nitrocellulose membranes (Nytran, Schleicher & Schuell) by downward alkaline capillary method (Chomczynski, 1992) and ®xed to the membrane by drying at 808C for 30 min. The nucleophosmin/B23 cDNA (Li et al., 1989) labeled with a-32 P-dCTP using a random primed kit (Promega) was employed as a probe for detection of homologous mRNA. Prehybridization was carried overnight at 428C in a solution containing 50% formamide, Denhardt's solution, 56SSC (16SSC=0.15 M NaCl, Figure 9 Eect of nucleophosmin/B23 antisense oligonucleotide on BuONa-induced decrease of telomerase activity. Ten micromolar nucleophosmin/B23 antisense (AS) or reverse oligomer was added to the HL-60 cell cultures. Control cultures were left untreated. After 1 day of oligomer treatment, the culture medium was replaced with fresh medium containing 10 mM nucleophosmin/B23 antisense or reverse oligomer. The cells were then incubated with 1 mM BuONa for 24 ± 96 h. (a) cells were harvested, washed and the lysates were centrifuged at 12 000 g for 30 min at 48C. The telomerase activities were then determined by TRAP assay. (b) Signal intensity in each lane was measured by area integration of the ®rst six ladders from the bottom of the gel using Phosphoimager. Relative telomerase activities were quantitated by comparing the signal intensity in each lane, and using that of reverse oligomer-transfected cells without BuONa treatment as 100% 0.015 M sodium citrate), 0.1% SDS, and 250 mg/ml denatured salmom sperm DNA. Radiolabeled probe at a speci®c activity of 1 ± 2610 9 c.p.m. ml was hybridized with total RNA in the same solution for 24 h at 428C. Washings of the membranes for the probes were: twice in 26SSC and 0.1% SDS at room temperature for 5 min; twice in 26SSC and 0.5% SDS at 428C for 10 min and once in 0.16SSC and 0.5% SDS at room temperature for 30 min. The radioactive nucleophosmin/B23 homologous mRNA was determined by autoradiography with phosphoimager or with intensifying screen at 7708C.
TRAP assay
The harvasted HL-60 cells (1610 6 ) were in 100 ml of 3-[(3-cholamidopropyl) -dimethyl-amminio] -1 -propanesulfonate lysis buer. After 30 min of incubation on ice, the lysates were centrifuged at 12 000 g for 30 min at 48C, and the supernatant was rapidly frozen and stored at 7808C. The concentration of protein was measured with Bio-Rad protein assay kit, and an aliquot of extract containing 0.1 mg of protein was used for each TRAP assay. Assay tubes were prepared by sequestering 0.1 mg of CX primer (5'-CCCTTACCCTTACCCTTACCCTAA-3') under mineral oil. Each extract was assayed in 30 ml of reaction mixture containing 20 mM Tris-HCl (pH 8.3), 1.5 mM MgCl 2 , 0.005% Tween 20, 1 mM EGTA, 50 mM dNTPs, 30 mCi [a-
32 P]dCTP, 0.1 mg of TS oligonucleotide (5'-AATCCGTCGAGCAGAGTT-3'), 0.1 mg/ml BSA and 1.5 units of Taq DNA polymerase (GIBCO ± BRL, Gaithersburg, MD). After a 20 min incubation at room temperature for telomerase-mediated extension of the TS primer, 0.1 mg of CX primer was added and the reaction mixture was heated at 908C for 90 s and then subjected to 30 PCR cycles of 948C for 30 s, 508C for 30 s, and 728C for 90 s. The PCR product was electrophoresed on a 15% polyacrylamide gel. For estimation of telomerase activity, positive extracts were reexamined by serial dilutions.
Transfection with antisense nucleophosmin/B23 oligonucleotides HL-60 cells were seeded at a density of 3610 5 per well in 1.0 ml OPTI-MEM I reduced serum medium (Gibco). Ten micromolar nucleophosmin/B23 antisense or reverse oligonucleotide and 6 mg lipofectin reagents in OPTI-MEM I reduced serum medium were mixed gently. The mixture was incubated for 45 min at room temperature, added to the HL-60 cells and was incubated for 24 h at 378C in the CO 2 incubator. The culture medium was then replaced with fresh RPMI1640 medium containing 10 mM nucleophosmin/B23 antisense or reverse oligonucleotide. The cells were incubated with 1 mM BuONa for 24 ± 96 h. Five micromolar nucleophosmin/B23 antisense or reverse oligonucleotide was further added on the second and third day of BuONa treatments.
Transient transfection by electroporation
Exponentially growing HL-60 cells was resuspended in fresh RPMI 1640 medium, at a cell density of 5610 7 cells/ ml. Two hundred microliters of this cell suspension (1610 7 cells) were combined with 40 mg of reporter plasmid and then transferred to a electroporation cuvette (GIBCO). DNA was introduced into HL-60 cells by delivery of a charge to the cell suspension using a CELL-PORATOR ELECTROPORATION System I (GIBCO) set at 300 V and 800 mF. The cell suspension was then removed to a culture¯ask containing 30 ml of supplemented RPMI 1640 medium. After 24 h, cells were treated with BuONa/ vanadate and harvested at another 24 or 48 h.
CAT assay
The cells were harvested and lysed by repeated freeze-thaw cycles in a buer containing 0.25 M Tris-Cl, pH 8.0. The cell lysates were then incubated at 608C for 10 min. CAT activity was measured by incubating cell lysates (equal amount of proteins) at 378C for 8 h with [ 14 C]chloramphenicol and acetyl coenzyme A. The mixture was extracted with ethyl acetate. The acetylated products were subjected to thin layer chromatography using chloroform: methanol (95 : 5) as a mobile phase. Quantitation of CAT activity was determined by autoradiography with phosphoimager.
